298 related articles for article (PubMed ID: 16783499)
1. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.
Yasutake C; Kuroda K; Yanagawa T; Okamura T; Yoneda H
Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):402-6. PubMed ID: 16783499
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population.
Passaro A; Dalla Nora E; Morieri ML; Soavi C; Sanz JM; Zurlo A; Fellin R; Zuliani G
J Gerontol A Biol Sci Med Sci; 2015 Mar; 70(3):294-302. PubMed ID: 24621946
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in Alzheimer's disease and vascular dementia.
Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
[TBL] [Abstract][Full Text] [Related]
4. Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia.
Konukoglu D; Andican G; Fırtına S; Erkol G; Kurt A
Acta Neurol Belg; 2012 Sep; 112(3):255-60. PubMed ID: 22740022
[TBL] [Abstract][Full Text] [Related]
5. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
[TBL] [Abstract][Full Text] [Related]
6. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
[TBL] [Abstract][Full Text] [Related]
7. Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression.
Zhao X; Li Y; Tian Q; Zhu B; Zhao Z
J Int Med Res; 2019 May; 47(5):1848-1855. PubMed ID: 30616482
[TBL] [Abstract][Full Text] [Related]
8. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
[TBL] [Abstract][Full Text] [Related]
9. Stage-dependent BDNF serum concentrations in Alzheimer's disease.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Wittorf A; Richartz E; Bartels M; Buchkremer G; Schott K
J Neural Transm (Vienna); 2006 Sep; 113(9):1217-24. PubMed ID: 16362629
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease.
Faria MC; Gonçalves GS; Rocha NP; Moraes EN; Bicalho MA; Gualberto Cintra MT; Jardim de Paula J; José Ravic de Miranda LF; Clayton de Souza Ferreira A; Teixeira AL; Gomes KB; Carvalho Md; Sousa LP
J Psychiatr Res; 2014 Jun; 53():166-72. PubMed ID: 24576746
[TBL] [Abstract][Full Text] [Related]
11. Serum brain-derived neurotrophic factor levels in different neurological diseases.
Ventriglia M; Zanardini R; Bonomini C; Zanetti O; Volpe D; Pasqualetti P; Gennarelli M; Bocchio-Chiavetto L
Biomed Res Int; 2013; 2013():901082. PubMed ID: 24024214
[TBL] [Abstract][Full Text] [Related]
12. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.
Angelucci F; Spalletta G; di Iulio F; Ciaramella A; Salani F; Colantoni L; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Bossù P
Curr Alzheimer Res; 2010 Feb; 7(1):15-20. PubMed ID: 20205668
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
[TBL] [Abstract][Full Text] [Related]
15. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.
Zuliani G; Ranzini M; Guerra G; Rossi L; Munari MR; Zurlo A; Volpato S; Atti AR; Blè A; Fellin R
J Psychiatr Res; 2007 Oct; 41(8):686-93. PubMed ID: 16600299
[TBL] [Abstract][Full Text] [Related]
16. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
[TBL] [Abstract][Full Text] [Related]
17. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
[TBL] [Abstract][Full Text] [Related]
18. Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.
Uslu S; Akarkarasu ZE; Ozbabalik D; Ozkan S; Colak O; Demirkan ES; Ozkiris A; Demirustu C; Alatas O
Neurochem Res; 2012 Jul; 37(7):1554-9. PubMed ID: 22437436
[TBL] [Abstract][Full Text] [Related]
19. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
[TBL] [Abstract][Full Text] [Related]
20. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.
Weinstein G; Beiser AS; Choi SH; Preis SR; Chen TC; Vorgas D; Au R; Pikula A; Wolf PA; DeStefano AL; Vasan RS; Seshadri S
JAMA Neurol; 2014 Jan; 71(1):55-61. PubMed ID: 24276217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
